Akebia Therapeutics (AKBA) Short-term Investments (2013 - 2021)
Akebia Therapeutics' Short-term Investments came in at $245,000 for Q4 2019, down 99.9% from $216.75 million a year earlier and down 98.9% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Short-term Investments (2013 - 2021) Analysis & Trends
Going back to Q4 2013, Akebia Therapeutics' Short-term Investments data covers 25 quarters.
- Short-term Investments carries a five-year compound annual growth rate of -68.3% (FY2014 to FY2019).
- Going back by year, Short-term Investments was $216.75 million in FY2018 (-12.5%), $247.64 million in FY2017 (+239.2%), $73.01 million in FY2016 (-17.7%) and $88.68 million in FY2015 (+16.5%).
- The Q4 2019 figure represents the lowest quarterly Short-term Investments in data going back to Q4 2013.
- Year-over-year, Short-term Investments has declined for six consecutive quarters, with an average decline of 34.7% over the last eight quarters.
- The fastest year-over-year change in Short-term Investments over five years came in Q4 2017 (growth of 239.2%), and the weakest in Q4 2019 (a decline of 99.9%).
- Business Quant data shows AKBA's Short-term Investments at $22.73 million (Q3 2019), $49.55 million (Q2 2019) and $105.3 million (Q1 2019) in the three quarters before Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Akebia Therapeutics | 149.86 Mn | -512.48 Mn | 30.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 20.00 Mn |
| Dec 31, 2020 | 39.99 Mn |
| Sep 30, 2020 | 99.97 Mn |
| Jun 30, 2020 | 49.94 Mn |
| Dec 31, 2019 | 245,000.00 |
| Sep 30, 2019 | 22.73 Mn |
| Jun 30, 2019 | 49.55 Mn |
| Mar 31, 2019 | 105.30 Mn |
| Dec 31, 2018 | 216.75 Mn |
| Sep 30, 2018 | 227.71 Mn |
| Jun 30, 2018 | 238.60 Mn |
| Mar 31, 2018 | 234.86 Mn |
| Dec 31, 2017 | 247.64 Mn |
| Sep 30, 2017 | 240.11 Mn |
| Jun 30, 2017 | 195.83 Mn |
| Mar 31, 2017 | 164.56 Mn |
| Dec 31, 2016 | 73.01 Mn |
| Sep 30, 2016 | 95.49 Mn |
| Jun 30, 2016 | 142.47 Mn |
| Mar 31, 2016 | 173.59 Mn |
API Access
Akebia Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();